SANDRA
RODRÍGUEZ PERALES
Profesora asociada
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (11)
2023
-
A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
Blood, Vol. 142, Núm. 20, pp. 1752-1756
-
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL
British Journal of Haematology
2022
-
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
EMBO molecular medicine, Vol. 14, Núm. 3, pp. e14552
-
Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility
Science Advances, Vol. 8, Núm. 44
-
OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells
Frontiers in Oncology, Vol. 12
2021
-
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
Nature Communications, Vol. 12, Núm. 1
2020
-
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
Nature Communications, Vol. 11, Núm. 1
-
TALEN mediated gene editing in a mouse model of Fanconi anemia
Scientific Reports, Vol. 10, Núm. 1
2019
-
NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia
Cell Stem Cell, Vol. 25, Núm. 5, pp. 607-621.e7
2017
-
Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
Stem Cell Reports, Vol. 8, Núm. 5, pp. 1408-1420
-
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients
EMBO Molecular Medicine, Vol. 9, Núm. 11, pp. 1574-1588